NCT01683305Unknown不适用
Biomarker Breast Pap Test
Silbiotech0 个研究点目标入组 500 人开始时间: 2013年3月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 500
研究概览
简要总结
This will be a Phase I study. During the Phase I study, our goals are: 1) screen a number of cancer biomarkers in Nipple Aspirate Fluid (NAF) from women who have no mammographically detectable tumors, and those who have detectable tumors, 2) identify all the detectable markers and 3) establish that biomarkers detected in NAF could also be detected in the biopsied tumor tissue that was removed for diagnostic purpose in subjects who have detectable tumors.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Any female subject aged 18 years or older
排除标准
- 未提供
研究者
Indira Poola, Ph.D
Principal Investigator
Silbiotech
相似试验
招募中
不适用
Prospective Screening for Breast Cancer-related LymphedemaLymphedemaNCT01521741Massachusetts General Hospital10,000
已完成
1 期
Study on the Safety, Anti-tumor Activity and Pharmacology of IPH2101 Combined With Lenalidomide in Patients With Multiple Myeloma Experiencing a First or Second RelapsePatients With Multiple Myeloma Experiencing aFirst or Second RelapseNCT01217203Innate Pharma15
已完成
不适用
Intervention to Promote Breast Cancer Screening Among American Indian WomenBreast CancerNCT05530603University of South Dakota133
终止
不适用
An In-vitro Standardization of B Cell Elispot AssaysTransplant SensitizationPanel Reactive AntibodySensitization to HLA AntigensNCT01334281Northwestern University19
已完成
1 期
Phase I/Ib Study of Pembrolizumab With Vorinostat for Patients With Advanced Renal or Urothelial Cell CarcinomaUrinary Bladder NeoplasmsRenal Cell CarcinomaNCT02619253Nabil Adra52